Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage (original) (raw)

References

1. Ecker A, Riemenschneider PA: Arteriographic demonstration of spasm of the intracranial arteries. With special reference to saccular arteial aneurisms. J Neurosurg 1951, 8: 660-667.
   CAS PubMed Google Scholar
2. Robertson EG: Cerebral lesions due to intracranial aneurysms. Brain 1949, 72: 150-185. 10.1093/brain/72.2.150
   CAS PubMed Google Scholar
3. Millikan CH: Cerebral vasospasm and ruptured intracranial aneurysm. Arch Neurol 1975, 32: 433-449.
   CAS PubMed Google Scholar
4. Fisher CM, Roberson GH, Ojemann RG: Cerebral vasospasm with ruptured saccular aneurysm – the clinical manifestations. Neurosurgery 1977, 1: 245-248. 10.1097/00006123-197711000-00004
   CAS PubMed Google Scholar
5. Sarrafzadeh AS, Haux D, Ludemann L, Amthauer H, Plotkin M, Kuchler I, Unterberg AW: Cerebral ischemia in aneurysmal subarachnoid hemorrhage: a correlative microdialysis-PET study. Stroke 2004, 35: 638-643. 10.1161/01.STR.0000116101.66624.F1
   PubMed Google Scholar
6. Vajkoczy P, Horn P, Thome C, Munch E, Schmiedek P: Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003, 98: 1227-1234.
   PubMed Google Scholar
7. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, et al.: Cerebral arterial spasm – a controlled trial of nimodipine in patients with subarachnoid hemorrhage. New Engl J Med 1983, 308: 619-624.
   CAS PubMed Google Scholar
8. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990, 73: 18-36.
   CAS PubMed Google Scholar
9. Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J Neurosurg 1990, 73: 37-47.
   CAS PubMed Google Scholar
10. Petruk KC, West M, Mohr G, Weir BK, Benoit BG, Gentili F, Disney LB, Khan MI, Grace M, Holness RO, et al.: Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 1988, 68: 505-517.
    CAS PubMed Google Scholar
11. Philippon J, Grob R, Dagreou F, Guggiari M, Rivierez M, Viars P: Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochirurgica 1986, 82: 110-114. 10.1007/BF01456369
    CAS PubMed Google Scholar
12. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P, et al.: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989, 298: 636-642.
    PubMed Central CAS PubMed Google Scholar
13. Manno EM, Gress DR, Schwamm LH, Diringer MN, Ogilvy CS: Effects of induced hypertension on transcranial Doppler ultrasound velocities in patients after subarachnoid hemorrhage. Stroke 1998, 29: 422-428.
    CAS PubMed Google Scholar
14. Soehle M, Czosnyka M, Pickard JD, Kirkpatrick PJ: Continuous assessment of cerebral autoregulation in subarachnoid hemorrhage. Anesthesia Analgesia 2004, 98: 1133-1139. 10.1213/01.ANE.0000111101.41190.99
    PubMed Google Scholar
15. Solenski NJ, Haley EC Jr, Kassell NF, Kongable G, Germanson T, Truskowski L, Torner JC: Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 1995, 23: 1007-1017. 10.1097/00003246-199506000-00004
    CAS PubMed Google Scholar
16. Adams HP Jr, Kassell NF, Torner JC, Haley EC Jr: Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study. Neurology 1987, 37: 1586-1591.
    PubMed Google Scholar
17. Wartenberg KE, Schmidt M, Fernandez A, Frontera JA, Claassen J, Ostapkovich ND, Badjatia N, Palestrant D, Parra A, Mayer SA: Multiterritorial symptomatic vasospasm after subarachnoid hemorrhage: predictors, associated complications, and impact on outcome. In International Stroke Conference: Feb 7–9, 2007; San Francisco. San Francisco, CA; 2007.
    Google Scholar
18. Ohman J, Servo A, Heiskanen O: Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 1991, 74: 8-13.
    CAS PubMed Google Scholar
19. Smith RR, Clower BR, Grotendorst GM, Yabuno N, Cruse JM: Arterial wall changes in early human vasospasm. Neurosurgery 1985, 16: 171-176. 10.1097/00006123-198502000-00008
    CAS PubMed Google Scholar
20. Macdonald RL, Weir BK: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991, 22: 971-982.
    CAS PubMed Google Scholar
21. Borsody M, Burke A, Coplin W, Miller-Lotan R, Levy A: Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage. Neurology 2006, 66: 634-640. 10.1212/01.wnl.0000200781.62172.1d
    CAS PubMed Google Scholar
22. Suzuki H, Muramatsu M, Kojima T, Taki W: Intracranial heme metabolism and cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2003, 34: 2796-2800. 10.1161/01.STR.0000103743.62248.12
    PubMed Google Scholar
23. Fuwa I, Mayberg M, Gadjusek C, Harada T, Luo Z: Enhanced secretion of endothelin by endothelial cells in response to hemoglobin. Neurologia Medico-chirurgica 1993, 33: 739-743.
    CAS PubMed Google Scholar
24. Misra HP, Fridovich I: The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem 1972, 247: 6960-6962.
    CAS PubMed Google Scholar
25. Rubanyi GM: Endothelium-derived relaxing and contracting factors. J Cell Biochem 1991, 46: 27-36. 10.1002/jcb.240460106
    CAS PubMed Google Scholar
26. Diringer MN: Subarachnoid hemorrhage: a multiple-organ system disease. Crit Care Med 2003, 31: 1884-1885. 10.1097/01.CCM.0000063528.09569.3A
    PubMed Google Scholar
27. Yoshimoto Y, Tanaka Y, Hoya K: Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 2001, 32: 1989-1993.
    CAS PubMed Google Scholar
28. Hendryk S, Jarzab B, Josko J: Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuroendocrinol Lett 2004, 25: 141-147. 10.1159/000079146
    CAS PubMed Google Scholar
29. Mocco J, Ransom ER, Komotar RJ, Mack WJ, Sergot PB, Albert SM, Connolly ES Jr: Racial differences in cerebral vasospasm: a systematic review of the literature. Neurosurgery 2006, 58: 305-314. 10.1227/01.NEU.0000195009.02412.E8
    CAS PubMed Google Scholar
30. Khurana VG, Sohni YR, Mangrum WI, McClelland RL, O'Kane DJ, Meyer FB, Meissner I: Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm. J Cereb Blood Flow Metab 2004, 24: 291-297. 10.1097/01.WCB.0000110540.96047.C7
    CAS PubMed Google Scholar
31. Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, Connolly ES, Mayer SA: Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke 2001, 32: 2012-2020.
    CAS PubMed Google Scholar
32. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980, 6: 1-9. 10.1097/00006123-198001000-00001
    CAS PubMed Google Scholar
33. Hijdra A, van Gijn J, Nagelkerke NJ, Vermeulen M, van Crevel H: Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke 1988, 19: 1250-1256.
    CAS PubMed Google Scholar
34. Qureshi AI, Sung GY, Suri MA, Straw RN, Guterman LR, Hopkins LN: Prognostic value and determinants of ultraearly angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1999, 44: 967-973. discussion 973–974 10.1097/00006123-199905000-00017
    CAS PubMed Google Scholar
35. de Oliveira JG, Beck J, Ulrich C, Rathert J, Raabe A, Seifert V: Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurgical Rev 2007, 30: 22-30. discussion 30–31 10.1007/s10143-006-0045-5
    Google Scholar
36. Gruber A, Ungersbock K, Reinprecht A, Czech T, Gross C, Bednar M, Richling B: Evaluation of cerebral vasospasm after early surgical and endovascular treatment of ruptured intracranial aneurysms. Neurosurgery 1998, 42: 258-267. discussion 267–268 10.1097/00006123-199802000-00032
    CAS PubMed Google Scholar
37. Macdonald RL, Rosengart A, Huo D, Karrison T: Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. J Neurosurg 2003, 99: 644-652.
    PubMed Google Scholar
38. Qureshi AI, Sung GY, Razumovsky AY, Lane K, Straw RN, Ulatowski JA: Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. Crit Care Med 2000, 28: 984-990. 10.1097/00003246-200004000-00012
    CAS PubMed Google Scholar
39. Roos Y, Rinkel G, Vermeulen M, Algra A, van Gijn J: Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review. Stroke 2003, 34: 2308-2309. 10.1161/01.STR.0000089030.04120.0E
    PubMed Google Scholar
40. Hop JW, Rinkel GJ, Algra A, van Gijn J: Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 1999, 30: 2268-2271.
    CAS PubMed Google Scholar
41. Juvela S, Siironen J, Kuhmonen J: Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg 2005, 102: 998-1003.
    PubMed Google Scholar
42. Lasner TM, Weil RJ, Riina HA, King JT Jr, Zager EL, Raps EC, Flamm ES: Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 1997, 87: 381-384.
    CAS PubMed Google Scholar
43. Weir BK, Kongable GL, Kassell NF, Schultz JR, Truskowski LL, Sigrest A: Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study. J Neurosurg 1998, 89: 405-411.
    CAS PubMed Google Scholar
44. Doerksen K, Naimark BJ, Tate RB: Comparison of a standard neurological tool with a stroke scale for detecting symptomatic cerebral vasospasm. J Neurosci Nurs 2002, 34: 320-325.
    PubMed Google Scholar
45. Newell DW, Grady MS, Eskridge JM, Winn HR: Distribution of angiographic vasospasm after subarachnoid hemorrhage: implications for diagnosis by transcranial Doppler ultrasonography. Neurosurgery 1990, 27: 574-577. 10.1097/00006123-199010000-00011
    CAS PubMed Google Scholar
46. Newell DW, Winn HR: Transcranial Doppler in cerebral vasospasm. Neurosurg Clin N Am 1990, 1: 319-328.
    CAS PubMed Google Scholar
47. Jarus-Dziedzic K, Juniewicz H, Wronski J, Zub WL, Kasper E, Gowacki M, Mierzwa J: The relation between cerebral blood flow velocities as measured by TCD and the incidence of delayed ischemic deficits. A prospective study after subarachnoid hemorrhage. Neurol Res 2002, 24: 582-592. 10.1179/016164102101200393
    PubMed Google Scholar
48. Lysakowski C, Walder B, Costanza MC, Tramer MR: Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: A systematic review. Stroke 2001, 32: 2292-2298.
    CAS PubMed Google Scholar
49. Suarez JI, Qureshi AI, Yahia AB, Parekh PD, Tamargo RJ, Williams MA, Ulatowski JA, Hanley DF, Razumovsky AY: Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Crit Care Med 2002, 30: 1348-1355. 10.1097/00003246-200206000-00035
    PubMed Google Scholar
50. Sviri GE, Britz GW, Lewis DH, Newell DW, Zaaroor M, Cohen W: Dynamic perfusion computed tomography in the diagnosis of cerebral vasospasm. Neurosurgery 2006, 59: 319-325. discussion 324–325 10.1227/01.NEU.0000222819.18834.33
    PubMed Google Scholar
51. Sviri GE, Mesiwala AH, Lewis DH, Britz GW, Nemecek A, Newell DW, Lam A, Cohen W: Dynamic perfusion computerized tomography in cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a comparison with technetium-99m-labeled ethyl cysteinate dimer-single-photon emission computerized tomography. J Neurosurg 2006, 104: 404-410.
    PubMed Google Scholar
52. Yonas H: Cerebral blood measurements in vasospasm. Neurosurg Clin N Am 1990, 1: 307-318.
    CAS PubMed Google Scholar
53. Yonas H, Sekhar L, Johnson DW, Gur D: Determination of irreversible ischemia by xenon-enhanced computed tomographic monitoring of cerebral blood flow in patients with symptomatic vasospasm. Neurosurgery 1989, 24: 368-372. 10.1097/00006123-198903000-00010
    CAS PubMed Google Scholar
54. Condette-Auliac S, Bracard S, Anxionnat R, Schmitt E, Lacour JC, Braun M, Meloneto J, Cordebar A, Yin L, Picard L: Vasospasm after subarachnoid hemorrhage: interest in diffusion-weighted MR imaging. Stroke 2001, 32: 1818-1824.
    CAS PubMed Google Scholar
55. Phan TG, Huston J 3rd, Campeau NG, Wijdicks EF, Atkinson JL, Fulgham JR: Value of diffusion-weighted imaging in patients with a nonlocalizing examination and vasospasm from subarachnoid hemorrhage. Cerebrovasc Dis 2003, 15: 177-181. 10.1159/000068823
    PubMed Google Scholar
56. Jabre A, Babikian V, Powsner RA, Spatz EL: Role of single photon emission computed tomography and transcranial Doppler ultrasonography in clinical vasospasm. J Clin Neurosci 2002, 9: 400-403. 10.1054/jocn.2002.1007
    PubMed Google Scholar
57. Lad SP, Guzman R, Kelly ME, Li G, Lim M, Lovbald K, Steinberg GK: Cerebral perfusion imaging in vasospasm. Neurosurgical Focus 2006, 21: E7.
    PubMed Google Scholar
58. Unterberg AW, Sakowitz OW, Sarrafzadeh AS, Benndorf G, Lanksch WR: Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2001, 94: 740-749.
    CAS PubMed Google Scholar
59. Mee E, Dorrance D, Lowe D, Neil-Dwyer G: Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 1988, 22: 484-491. 10.1097/00006123-198803000-00006
    CAS PubMed Google Scholar
60. Karinen P, Koivukangas P, Ohinmaa A, Koivukangas J, Ohman J: Cost-effectiveness analysis of nimodipine treatment after aneurysmal subarachnoid hemorrhage and surgery. Neurosurgery 1999, 45: 780-784. discussion 784–785 10.1097/00006123-199910000-00009
    CAS PubMed Google Scholar
61. Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J: Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Systematic Rev 2005, CD000277.
    Google Scholar
62. Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J: Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 1998, 50: 876-883.
    CAS PubMed Google Scholar
63. Abe K, Iwanaga H, Inada E: Effect of nicardipine and diltiazem on internal carotid artery blood flow velocity and local cerebral blood flow during cerebral aneurysm surgery for subarachnoid hemorrhage. J Clin Anesth 1994, 6: 99-105. 10.1016/0952-8180(94)90004-3
    CAS PubMed Google Scholar
64. Haley EC Jr, Kassell NF, Torner JC: A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg 1993, 78: 548-553.
    PubMed Google Scholar
65. Haley EC Jr, Kassell NF, Torner JC: A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 1993, 78: 537-547.
    PubMed Google Scholar
66. Papavasiliou AK, Harbaugh KS, Birkmeyer NJ, Feeney JM, Martin PB, Faccio C, Harbaugh RE: Clinical outcomes of aneurysmal subarachnoid hemorrhage patients treated with oral diltiazem and limited intensive care management. Surg Neurol 2001, 55: 138-146. discussion 146–147 10.1016/S0090-3019(01)00364-0
    CAS PubMed Google Scholar
67. Saunders FW, Marshall WJ: Diltiazem: dose it affect vasospasm? Surg Neurol 1986, 26: 155-158. 10.1016/0090-3019(86)90368-X
    CAS PubMed Google Scholar
68. Shibuya M, Suzuki Y, Enomoto H, Okada T, Ogura K, Sugita K: Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochirurgica 1994, 131: 19-25. 10.1007/BF01401450
    CAS PubMed Google Scholar
69. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 1997, 86: 467-474.
    CAS PubMed Google Scholar
70. Kassell NF, Haley EC Jr, Apperson-Hansen C, Alves WM: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 1996, 84: 221-228.
    CAS PubMed Google Scholar
71. Lanzino G, Kassell NF: Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg 1999, 90: 1018-1024.
    CAS PubMed Google Scholar
72. Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, Truskowski LL, Alves WM: Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg 1999, 90: 1011-1017.
    CAS PubMed Google Scholar
73. Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 1995, 82: 786-790.
    PubMed Google Scholar
74. Kanamaru K, Weir BK, Findlay JM, Grace M, Macdonald RL: A dosage study of the effect of the 21-aminosteroid U74006F on chronic cerebral vasospasm in a primate model. Neurosurgery 1990, 27: 29-38. 10.1097/00006123-199007000-00004
    CAS PubMed Google Scholar
75. Steinke DE, Weir BK, Findlay JM, Tanabe T, Grace M, Krushelnycky BW: A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 1989, 24: 179-186. 10.1097/00006123-198902000-00005
    CAS PubMed Google Scholar
76. Suzuki H, Kanamaru K, Kuroki M, Sun H, Waga S, Miyazawa T: Effects of tirilazad mesylate on vasospasm and phospholipid hydroperoxides in a primate model of subarachnoid hemorrhage. Stroke 1999, 30: 450-455. discussion 455–456
    CAS PubMed Google Scholar
77. Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner B: Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 2001, 49: 593-605. discussion 605–606 10.1097/00006123-200109000-00012
    CAS PubMed Google Scholar
78. Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, Wu YC, Klebanoff LM, Raps EC, Solomon RA: Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 2000, 31: 383-391.
    CAS PubMed Google Scholar
79. Rinkel GJ, Feigin VL, Algra A, van Gijn J: Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Systematic Rev 2004, CD000483.
    Google Scholar
80. Suarez JI, Shannon L, Zaidat OO, Suri MF, Singh G, Lynch G, Selman WR: Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J Neurosurg 2004, 100: 585-590.
    CAS PubMed Google Scholar
81. Amin-Hanjani S, Ogilvy CS, Barker FG 2nd: Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 2004, 54: 326-334. discussion 334–335 10.1227/01.NEU.0000103488.94855.4F
    PubMed Google Scholar
82. Sasaki T, Ohta T, Kikuchi H, Takakura K, Usui M, Ohnishi H, Kondo A, Tanabe H, Nakamura J, Yamada K, et al.: A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1994, 35: 597-604. discussion 604–605 10.1097/00006123-199410000-00004
    CAS PubMed Google Scholar
83. Zabramski JM, Spetzler RF, Lee KS, Papadopoulos SM, Bovill E, Zimmerman RS, Bederson JB: Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1991, 75: 189-196.
    CAS PubMed Google Scholar
84. Findlay JM, Kassell NF, Weir BK, Haley EC Jr, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW, et al.: A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 1995, 37: 168-176. discussion 177–178
    CAS PubMed Google Scholar
85. Kinouchi H, Ogasawara K, Shimizu H, Mizoi K, Yoshimoto T: Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage. Neurologia Medico-chirurgica 2004, 44: 569-575. discussion 576–577 10.2176/nmc.44.569
    PubMed Google Scholar
86. Hamada J, Kai Y, Morioka M, Yano S, Mizuno T, Hirano T, Kazekawa K, Ushio Y: Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study. Stroke 2003, 34: 2549-2554. 10.1161/01.STR.0000094731.63690.FF
    PubMed Google Scholar
87. Sasaki T, Kodama N, Kawakami M, Sato M, Asari J, Sakurai Y, Watanabe K, Onuma T, Matsuda T: Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a study of urokinase concentration and the fibrinolytic system. Stroke 2000, 31: 1256-1262.
    CAS PubMed Google Scholar
88. Klimo P Jr, Kestle JR, MacDonald JD, Schmidt RH: Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 2004, 100: 215-224.
    PubMed Google Scholar
89. Muizelaar JP, Zwienenberg M, Rudisill NA, Hecht ST: The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study. J Neurosurg 1999, 91: 51-58.
    CAS PubMed Google Scholar
90. Zwienenberg-Lee M, Hartmann J, Rudisill N, Muizelaar JP: The effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage. Results of a multi-center randomized clinical trial. In International Stroke Conference: Feb 7–9, 2007; San Francisco. San Francisco, CA; 2007.
    Google Scholar
91. Hoh BL, Ogilvy CS: Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg Clin N Am 2005, 16: 501-516. vi 10.1016/j.nec.2005.04.004
    PubMed Google Scholar
92. Jost SC, Diringer MN, Zazulia AR, Videen TO, Aiyagari V, Grubb RL, Powers WJ: Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage. J Neurosurg 2005, 103: 25-30.
    PubMed Google Scholar
93. Aiyagari V, Cross DT 3rd, Deibert E, Dacey RG Jr, Diringer MN: Safety of hemodynamic augmentation in patients treated with Guglielmi detachable coils after acute aneurysmal subarachnoid hemorrhage. Stroke 2001, 32: 1994-1997.
    CAS PubMed Google Scholar
94. Miller JA, Dacey RG Jr, Diringer MN: Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 1995, 26: 2260-2266.
    CAS PubMed Google Scholar
95. Mindea SA, Yang BP, Bendok BR, Miller JW, Batjer HH: Endovascular treatment strategies for cerebral vasospasm. Neurosurgical Focus 2006, 21: E13.
    PubMed Google Scholar
96. Brisman JL, Eskridge JM, Newell DW: Neurointerventional treatment of vasospasm. Neurological Res 2006, 28: 769-776. 10.1179/016164106X152043
    CAS Google Scholar
97. Coyne TJ, Montanera WJ, Macdonald RL, Wallace MC: Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Can J Surg 1994, 37: 391-396.
    CAS PubMed Google Scholar
98. Murai Y, Kominami S, Kobayashi S, Mizunari T, Teramoto A: The long-term effects of transluminal balloon angioplasty for vasospasms after subarachnoid hemorrhage: analyses of cerebral blood flow and reactivity. Surg Neurol 2005, 64: 122-126. discussion 127 10.1016/j.surneu.2004.11.036
    PubMed Google Scholar
99. Polin RS, Coenen VA, Hansen CA, Shin P, Baskaya MK, Nanda A, Kassell NF: Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2000, 92: 284-290.
    CAS PubMed Google Scholar
100. Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J: Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 1999, 44: 975-979. discussion 979–980 10.1097/00006123-199905000-00022
     CAS PubMed Google Scholar
101. Rabinstein AA, Friedman JA, Nichols DA, Pichelmann MA, McClelland RL, Manno EM, Atkinson JL, Wijdicks EF: Predictors of outcome after endovascular treatment of cerebral vasospasm. Am J Neuroradiol 2004, 25: 1778-1782.
     PubMed Google Scholar
102. Yamamoto Y, Smith RR, Bernanke DH: Mechanism of action of balloon angioplasty in cerebral vasospasm. Neurosurgery 1992, 30: 1-5. discussion 5–6
     CAS PubMed Google Scholar
103. Firlik KS, Kaufmann AM, Firlik AD, Jungreis CA, Yonas H: Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Surg Neurol 1999, 51: 66-74. 10.1016/S0090-3019(97)00370-4
     CAS PubMed Google Scholar
104. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS: Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 1992, 77: 848-852.
     CAS PubMed Google Scholar
105. Liu JK, Tenner MS, Gottfried ON, Stevens EA, Rosenow JM, Madan N, MacDonald JD, Kestle JR, Couldwell WT: Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J Neurosurg 2004, 100: 414-421.
     CAS PubMed Google Scholar
106. Milburn JM, Moran CJ, Cross DT 3rd, Diringer MN, Pilgram TK, Dacey RG Jr: Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration. J Neurosurg 1998, 88: 38-42.
     CAS PubMed Google Scholar
107. Vajkoczy P, Horn P, Bauhuf C, Munch E, Hubner U, Ing D, Thome C, Poeckler-Schoeninger C, Roth H, Schmiedek P: Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm. Stroke 2001, 32: 498-505.
     CAS PubMed Google Scholar
108. Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF: Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 1998, 42: 1256-1264. discussion 1264–1267 10.1097/00006123-199806000-00031
     CAS PubMed Google Scholar
109. McAuliffe W, Townsend M, Eskridge JM, Newell DW, Grady MS, Winn HR: Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm. J Neurosurg 1995, 83: 430-434.
     CAS PubMed Google Scholar
110. Barr JD, Mathis JM, Horton JA: Transient severe brain stem depression during intraarterial papaverine infusion for cerebral vasospasm. Am J Neuroradiol 1994, 15: 719-723.
     CAS PubMed Google Scholar
111. Clyde BL, Firlik AD, Kaufmann AM, Spearman MP, Yonas H: Paradoxical aggravation of vasospasm with papaverine infusion following aneurysmal subarachnoid hemorrhage. Case report. J Neurosurg 1996, 84: 690-695.
     CAS PubMed Google Scholar
112. Tsurushima H, Kamezaki T, Nagatomo Y, Hyodo A, Nose T: Complications associated with intraarterial administration of papaverine for vasospasm following subarachnoid hemorrhage – two case reports. Neurologia Medico-chirurgica 2000, 40: 112-115. 10.2176/nmc.40.112
     CAS PubMed Google Scholar
113. Smith WS, Dowd CF, Johnston SC, Ko NU, DeArmond SJ, Dillon WP, Setty D, Lawton MT, Young WL, Higashida RT, et al.: Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2004, 35: 2518-2522. 10.1161/01.STR.0000144682.00822.83
     CAS PubMed Google Scholar
114. Carhuapoma JR, Qureshi AI, Tamargo RJ, Mathis JM, Hanley DF: Intra-arterial papaverine-induced seizures: case report and review of the literature. Surg Neurol 2001, 56: 159-163. 10.1016/S0090-3019(01)00450-5
     CAS PubMed Google Scholar
115. Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, Rordorf GA: Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. Am J Neuroradiol 2004, 25: 819-826.
     PubMed Google Scholar
116. Feng L, Fitzsimmons BF, Young WL, Berman MF, Lin E, Aagaard BD, Duong H, Pile-Spellman J: Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. Am J Neuroradiol 2002, 23: 1284-1290.
     PubMed Google Scholar
117. Biondi A, Ricciardi GK, Puybasset L, Abdennour L, Longo M, Chiras J, Van Effenterre R: Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. Am J Neuroradiol 2004, 25: 1067-1076.
     PubMed Google Scholar
118. Hui C, Lau KP: Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage. Clin Radiol 2005, 60: 1030-1036. 10.1016/j.crad.2005.04.004
     CAS PubMed Google Scholar
119. van den Bergh WM, Algra A, van der Sprenkel JW, Tulleken CA, Rinkel GJ: Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003, 52: 276-281. discussion 281–282 10.1227/01.NEU.0000043984.42487.0E
     PubMed Google Scholar
120. Collignon FP, Friedman JA, Piepgras DG, Pichelmann MA, McIver JI, Toussaint LG 3rd, McClelland RL: Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage. Neurocritical Care 2004, 1: 441-448. 10.1385/NCC:1:4:441
     PubMed Google Scholar
121. Muir KW: Magnesium in stroke treatment. Postgrad Med J 2002, 78: 641-645. 10.1136/pmj.78.925.641
     PubMed Central CAS PubMed Google Scholar
122. van den Bergh WM, Albrecht KW, Berkelbach van der Sprenkel JW, Rinkel GJ: Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment. Acta Neurochirurgica 2003, 145: 195-199. discussion 199 10.1007/s00701-002-1064-9
     CAS PubMed Google Scholar
123. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD, Malik GM: Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002, 96: 510-514.
     CAS PubMed Google Scholar
124. Izumi Y, Roussel S, Pinard E, Seylaz J: Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1991, 11: 1025-1030.
     CAS PubMed Google Scholar
125. Marinov MB, Harbaugh KS, Hoopes PJ, Pikus HJ, Harbaugh RE: Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 1996, 85: 117-124.
     CAS PubMed Google Scholar
126. Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M: Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 1991, 22: 922-927.
     CAS PubMed Google Scholar
127. van den Bergh WM, Zuur JK, Kamerling NA, van Asseldonk JT, Rinkel GJ, Tulleken CA, Nicolay K: Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage. J Neurosurg 2002, 97: 416-422.
     CAS PubMed Google Scholar
128. Boet R, Mee E: Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery 2000, 47: 602-606. discussion 606–607 10.1097/00006123-200009000-00014
     CAS PubMed Google Scholar
129. Wong GK, Chan MT, Boet R, Poon WS, Gin T: Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study. J Neurosurg Anesthesiol 2006, 18: 142-148. 10.1097/00008506-200604000-00009
     PubMed Google Scholar
130. Saver JL, Kidwell C, Eckstein M, Starkman S: Prehospital neuro-protective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke 2004, 35: e106-108. 10.1161/01.STR.0000124458.98123.52
     CAS PubMed Google Scholar
131. Yahia AM, Kirmani JF, Qureshi AI, Guterman LR, Hopkins LN: The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocritical Care 2005, 3: 16-23. 10.1385/NCC:3:1:016
     CAS PubMed Google Scholar
132. van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, Rinkel GJ: Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005, 36: 1011-1015. 10.1161/01.STR.0000160801.96998.57
     CAS PubMed Google Scholar
133. Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ: Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery 2006, 58: 1054-1065. 10.1227/01.NEU.0000215868.40441.D9
     PubMed Google Scholar
134. Prevedello DM, Cordeiro JG, de Morais AL, Saucedo NS Jr, Chen IB, Araujo JC: Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity. Surg Neurol 2006, 65: S1:14-1:20. 10.1016/j.surneu.2005.11.035
     Google Scholar
135. Brewer RP, Parra A, Lynch J, Chilukuri V, Borel CO: Cerebral blood flow velocity response to magnesium sulfate in patients after subarachnoid hemorrhage. J Neurosurg Anesthesiol 2001, 13: 202-206. 10.1097/00008506-200107000-00004
     CAS PubMed Google Scholar
136. Amin-Hanjani S, Stagliano NE, Yamada M, Huang PL, Liao JK, Moskowitz MA: Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 2001, 32: 980-986.
     CAS PubMed Google Scholar
137. Laufs U, Fata VL, Liao JK: Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem 1997, 272: 31725-31729. 10.1074/jbc.272.50.31725
     CAS PubMed Google Scholar
138. Yamada M, Huang Z, Dalkara T, Endres M, Laufs U, Waeber C, Huang PL, Liao JK, Moskowitz MA: Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J Cereb Blood Flow Metab 2000, 20: 709-717.
     CAS PubMed Google Scholar
139. Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ: Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005, 36: 1627-1632. 10.1161/01.STR.0000176743.67564.5d
     CAS PubMed Google Scholar
140. Lynch JR, Wang H, McGirt MJ, Floyd J, Friedman AH, Coon AL, Blessing R, Alexander MJ, Graffagnino C, Warner DS, et al.: Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 2005, 36: 2024-2026. 10.1161/01.STR.0000177879.11607.10
     CAS PubMed Google Scholar
141. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327: 524-526. 10.1038/327524a0
     CAS PubMed Google Scholar
142. Faraci FM: Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation. Am J Physiol 1991, 261: H1038-1042.
     CAS PubMed Google Scholar
143. Prado R, Watson BD, Kuluz J, Dietrich WD: Endothelium-derived nitric oxide synthase inhibition. Effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats. Stroke 1992, 23: 1118-1123. discussion 1124
     CAS PubMed Google Scholar
144. You J, Johnson TD, Marrelli SP, Mombouli JV, Bryan RM Jr: P2u receptor-mediated release of endothelium-derived relaxing factor/nitric oxide and endothelium-derived hyperpolarizing factor from cerebrovascular endothelium in rats. Stroke 1999, 30: 1125-1133.
     CAS PubMed Google Scholar
145. Raabe A, Zimmermann M, Setzer M, Vatter H, Berkefeld J, Seifert V: Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm. Neurosurgery 2002, 50: 1006-1013. discussion 1013–1014 10.1097/00006123-200205000-00013
     PubMed Google Scholar
146. Kumar R, Pathak A, Mathuriya SN, Khandelwal N: Intraventricular sodium nitroprusside therapy: a future promise for refractory subarachnoid hemorrhage-induced vasospasm. Neurol India 2003, 51: 197-202.
     CAS PubMed Google Scholar
147. Thomas JE, Rosenwasser RH: Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intra-ventricular sodium nitroprusside in humans. Neurosurgery 1999, 44: 48-57. discussion 57–58 10.1097/00006123-199901000-00026
     CAS PubMed Google Scholar
148. Reinert M, Wiest R, Barth L, Andres R, Ozdoba C, Seiler R: Transdermal nitroglycerin in patients with subarachnoid hemorrhage. Neurol Res 2004, 26: 435-439. 10.1179/016164104225015976
     CAS PubMed Google Scholar
149. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332: 411-415. 10.1038/332411a0
     CAS PubMed Google Scholar
150. Davenport AP, Maguire JJ: Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans? Trends Pharmacol Sci 1994, 15: 9-11. 10.1016/0165-6147(94)90120-1
     CAS PubMed Google Scholar
151. Hosoda K, Nakao K, Hiroshi A, Suga S, Ogawa Y, Mukoyama M, Shirakami G, Saito Y, Nakanishi S, Imura H: Cloning and expression of human endothelin-1 receptor cDNA. FEBS letters 1991, 287: 23-26. 10.1016/0014-5793(91)80007-P
     CAS PubMed Google Scholar
152. Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, Davenport AP: Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circulation Res 1993, 72: 526-538.
     CAS PubMed Google Scholar
153. Ogawa Y, Nakao K, Arai H, Nakagawa O, Hosoda K, Suga S, Nakanishi S, Imura H: Molecular cloning of a non-isopeptide-selective human endothelin receptor. Biochem Biophys Res Comm 1991, 178: 248-255. 10.1016/0006-291X(91)91806-N
     CAS PubMed Google Scholar
154. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P: Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 2005, 103: 9-17.
     CAS PubMed Google Scholar
155. Shaw MD, Vermeulen M, Murray GD, Pickard JD, Bell BA, Teasdale GM: Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group. J Neurosurg 2000, 93: 992-997.
     CAS PubMed Google Scholar
156. Macdonald RL, Kassell N, Mayer S, Schmiedek P, Weidauer S, Pasqualin A: Randomized trial of Clazosentan for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. In International Stroke Conference: Feb 7–9, 2007; San Francisco. San Francisco, CA; 2007.
     Google Scholar
157. Wurm G, Tomancok B, Nussbaumer K, Adelwohrer C, Holl K: Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosurg 2004, 106: 97-103. 10.1016/j.clineuro.2004.01.006
     PubMed Google Scholar
158. Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T: Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 2005, 56: 895-902.
     PubMed Google Scholar
159. Kasuya H, Onda H, Takeshita M, Okada Y, Hori T: Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 2002, 33: 1011-1015. 10.1161/01.STR.0000014563.75483.22
     CAS PubMed Google Scholar
160. Barth M, Capelle HH, Weidauer S, Weiss C, Munch E, Thome C, Luecke T, Schmiedek P, Kasuya H, Vajkoczy P: Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 2007, 38: 330-336. 10.1161/01.STR.0000254601.74596.0f
     CAS PubMed Google Scholar
161. Garcia-Pastor C, Rios C, Nathal E: Neuroprotector effect of Dapsone in patients with subarachnoid hemorrhage: A controlled study. In International Stroke Conference: Feb 7–9, 2007; San Francisco. San Francisco, CA; 2007.
     Google Scholar
162. Keller E, Krayenbuhl N, Bjeljac M, Yonekawa Y: Cerebral vasospasm: results of a structured multimodal treatment. Acta Neurochir Suppl 2005, 94: 65-73.
     CAS PubMed Google Scholar

Download references